Proactive review for people with diabetes in hospital: a cluster randomised feasibility study and process evaluation

Cambridge University Hospitals NHS Foundation Trust0 个研究点目标入组 287 人开始时间: 2022年2月21日最近更新: 2024年7月8日

适应症

试验速览

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38863071/ (added 19/06/2024)

•The main trial will recruit both wards (clusters) and patients:
•1. Wards: General adult medical and surgical wards are eligible. The specialist diabetes wards, day-case units, maternity wards and paediatric areas (age <16 years) are excluded.
•2. Patients: Adult patients with a diagnosis of diabetes documented on their problem list admitted to one of the included wards will be eligible. Inpatients already under the care of the specialist diabetes team in hospital will be excluded.
•The process evaluation will include both a sub-sample of patients from the trial and health care professionals:
•1. Patients: All patients with diabetes admitted to an included ward and taking part in the trial will be eligible.
•2. Healthcare professionals: Nurses and Doctors that are permanent members of staff on an included ward will be eligible, along with all members of the diabetes inpatient specialist nurse team responsible for delivering the proactive diabetes review model (intervention). As key stakeholders, divisional leads with service development, budget assignment and strategic decision-making responsibilities will also be eligible and known as managers for the purpose of this protocol.

•1. Inpatients already under the care of the specialist diabetes team in the hospital
•2. <16 years old

发起方